The Effect of Psychological Factors on COVID-19 Vaccination Side Effects: A Cross-Sectional Survey in South Korea

키워드

참고문헌 (52)

1. Umakanthan S, "Origin, transmission, diagnosis and management of coronavirus disease 2019(COVID-19)", Postgrad Med J, 96, pp.753~758 (2020)
2. Wu F, "A new coronavirus associated with human respiratory disease in China", Nature, 579, pp.265~269 (2020)
3. Lazarus JV, "A global survey of potential acceptance of a COVID-19 vaccine", Nat Med, 27, pp.225~228 (2021)
4. Kwok KO, "Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses : a survey", Int J Nurs Stud, 114, pp.103854~ (2021)
5. Luyten J, "Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument", Vaccine, 37, pp.2494~2501 (2019)
6. Szmyd B, "Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: a cross-sectional study from Poland", Vaccines(Basel), 9, pp.218~ (2021)
7. Hwang SE, "Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020", Hum Vaccin Immunother, 18, pp.1~8 (2022)
8. Gargano JW, "Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients : update from the Advisory Committee on Immunization Practices-United States, June 2021", MMWR Morb Mortal Wkly Rep, 70, pp.977~982 (2021)
9. Salah HM, "COVID-19 vaccine and myocarditis", Am J Cardiol, 157, pp.146~148 (2021)
10. Greinacher A, "Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination", N Engl JMed, 384, pp.2092~2101 (2021)
11. Vogel G, "Side effect worry grows for AstraZeneca vaccine", Science, 372, pp.14~15 (2021)
12. Kadali RAK, "Non-life-threatening adverse effects with COVID-19mRNA-1273 vaccine : a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms", J Med Virol, 93, pp.4420~4429 (2021)
13. Solís Arce JS, "COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries", Nat Med, 27, pp.1385~1394 (2021)
14. Banerjee D, "The COVID-19 outbreak : crucial role the psychiatrists can play", Asian J Psychiatr, 50, pp.102014~ (2020)
15. Madison AA, "Psychological and behavioral predictors of vaccine efficacy : considerations for COVID-19", Perspect Psychol Sci, 16, pp.191~203 (2021)
16. Riad A, "Prevalence and risk factors of CoronaVac side effects : an independent cross-sectional study among healthcare workers in Turkey", J Clin Med, 10, pp.2629~ (2021)
17. Ganesan S, "Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study", Front Public Health, 10, pp.876336~ (2022)
18. Geers AL, "Psychosocial factors predict COVID-19 vaccine side effects", Psychother Psychosom, 91, pp.136~138 (2022)
19. Gold MS, "Immunization stress-related response–redefining immunization anxiety-related reaction as an adverse event following immunization", Vaccine, 38, pp.3015~3020 (2020)
20. Brydon L, "Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans", Brain Behav Immun, 23, pp.217~224 (2009)
21. Barsky AJ, "The somatosensory amplification scale and its relationship to hypochondriasis", J Psychiatr Res, 24, pp.323~334 (1990)
22. Bendau A, "COVID-19 vaccine hesitancy and related fears and anxiety", Int Immunopharmacol, 97, pp.107724~ (2021)
23. Gerretsen P, "Individual determinants of COVID-19 vaccine hesitancy", PLoS One, 16, pp.e0258462~ (2021)
24. Betsch C, "Beyond confidence : development of a measure assessing the 5C psychological antecedents of vaccination", PLoS One, 13, pp.e0208601~ (2018)
25. Majumder MAA, "Prevalence of COVID-19 vaccine reactogenicity among Bangladeshi physicians", FASEB Bioadv, 4, pp.379~390 (2022)
26. Kroenke K, "The PHQ-9 : validity of a brief depression severity measure", J Gen Intern Med, 16, pp.606~613 (2001)
27. Spitzer RL, "A brief measure for assessing generalized anxiety disorder : the GAD-7", Arch Intern Med, 166, pp.1092~1097 (2006)
28. Nakao M, "Clinical application of somatosensory amplification in psychosomatic medicine", Biopsychosoc Med, 1, pp.17~ (2007)
29. Speckens AE, "The diagnostic and prognostic significance of the Whitely Index, the Illness Attitude Scales and the Somatosensory Amplification Scale", Psychol Med, 26, pp.1085~1090 (1996)
30. Stewart SH, "Illness Attitudes Scale dimensions and their associations with anxiety-related constructs in a nonclinical sample", Behav Res Ther, 38, pp.83~99 (2000)
31. Sirri L, "The Illness Attitude Scales : a clinimetric index for assessing hypochondriacal fears and beliefs", Psychother Psychosom, 77, pp.337~350 (2008)
32. Chapin-Bardales J, "Reactogenicity following receipt of mRNA-based COVID-19 vaccines", JAMA, 325, pp.2201~2202 (2021)
33. Mahallawi WH, "Reactogenicity and immunogenicity of the Pfizer and AstraZeneca COVID-19 vaccines", Front Immunol, 12, pp.794642~ (2021)
34. Saita M, "Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine : real-world evidence from healthcare workers in Japan", J Infect Chemother, 28, pp.116~119 (2022)
35. Folegatti PM, "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 : a preliminary report of a phase 1", 2, singleblind, randomised controlled trial, 2020, pp.396, 467~478
36. "Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventative vaccine clinical trials"[URL]
37. Ahsan W, "Post-vaccination survey for monitoring the side effects associated with COVID-19 vaccines among healthcare professionals of Jazan province, Saudi Arabia", Saudi Med J, 42, pp.1341~1352 (2021)
38. Beatty AL, "Analysis of COVID-19 vaccine type and adverse effects following vaccination", JAMA Netw Open, 4, pp.e2140364~ (2021)
39. Riad A, "Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic", J Clin Med, 10, pp.1428~ (2021)
40. Liu Y, "Dysfunction in serotonergic and noradrenergic systems and somatic symptoms in psychiatric disorders", Front Psychiatry, 10, pp.286~ (2019)
41. Hervé C, "The how’s and what’s of vaccine reactogenicity", NPJ Vaccines, 4, pp.39~ (2019)
42. Muric G, "COVID-19 vaccine hesitancy on social media : building a public Twitter data set of antivaccine content, vaccine misinformation, and conspiracies", JMIR Public Health Surveill, 7, pp.e30642~ (2021)
43. Rief W, "Fear of adverse effects and COVID-19 vaccine hesitancy : recommendations of the treatment expectation expert group", JAMA Health Forum, 2, pp.e210804~ (2021)
44. Hernandez RG, "The COVID-19 vaccine social media infodemic : healthcare providers’ missed dose in addressing misinformation and vaccine hesitancy", Hum Vaccin Immunother, 17, pp.2962~2964 (2021)
45. Fernández-Penny FE, "COVID-19 vaccine hesitancy among patients in two urban emergency departments", Acad Emerg Med, 28, pp.1100~1107 (2021)
46. Dambadarjaa D, "Factors associated with COVID-19 vaccine hesitancy in Mongolia : a web-based cross-sectional survey", Int J Environ Res Public Health, 18, pp.12903~ (2021)
47. Biasio LR, "Vaccine hesitancy and health literacy", Hum Vaccin Immunother, 13, pp.701~702 (2017)
48. Ferreri F, "Current research on cognitive aspects of anxiety disorders", Curr Opin Psychiatry, 24, pp.49~54 (2011)
49. Hall KT, "Reactogenicity and concomitant administration of the COVID-19 booster and influenza vaccine", JAMA Netw Open, 5, pp.e2222246~ (2022)
50. Haas JW, "Frequency of adverse events in the placebo arms of COVID-19 vaccine trials : a systematic review and meta-analysis", JAMA Netw Open, 5, pp.e2143955~ (2022)
51. Smith LE, "Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects : a cross-sectional survey in England", Vaccine, 35, pp.1936~1945 (2017)
52. Mathioudakis AG, "Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey", Life(Basel), 11, pp.249~ (2021)

관련 논문AI추천